{
  "thread": {
    "uuid": "93152a04266f080e5beea4d0ce2fa712d9b388eb",
    "url": "https://finance.sina.com.cn/stock/aiassist/pzzd/2026-01-15/doc-inhhkmpr7580943.shtml?cref=cj",
    "site_full": "finance.sina.com.cn",
    "site": "sina.com.cn",
    "site_section": "https://finance.sina.cn/",
    "site_categories": [
      "tech",
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news",
      "politics",
      "science and technology",
      "economy, business and finance"
    ],
    "section_title": "新浪财经_金融信息服务商",
    "site_title": "æ°æµªè´¢ç»_éèä¿¡æ¯æå¡å",
    "title": "科源制药跌2.02%，成交额7529.16万元，主力资金净流出113.34万元|科源制药_新浪财经_新浪网",
    "title_full": "科源制药跌2.02%，成交额7529.16万元，主力资金净流出113.34万元|科源制药_新浪财经_新浪网",
    "published": "2026-01-15T08:08:00.000+02:00",
    "replies_count": 0,
    "participants_count": 1,
    "site_type": "news",
    "country": "CN",
    "main_image": "",
    "performance_score": 0,
    "domain_rank": 548,
    "domain_rank_updated": "2026-01-11T23:00:00.000+02:00",
    "licensing_agency": [],
    "social": {
      "facebook": {
        "likes": 0,
        "comments": 0,
        "shares": 0
      },
      "vk": {
        "shares": 0
      }
    }
  },
  "uuid": "93152a04266f080e5beea4d0ce2fa712d9b388eb",
  "url": "https://finance.sina.com.cn/stock/aiassist/pzzd/2026-01-15/doc-inhhkmpr7580943.shtml?cref=cj",
  "ord_in_thread": 0,
  "author": "小浪财讯",
  "published": "2026-01-15T08:08:00.000+02:00",
  "title": "科源制药跌2.02%，成交额7529.16万元，主力资金净流出113.34万元|科源制药_新浪财经_新浪网",
  "text": "1月15日， 科源制药 盘中下跌2.02%，截至14:08，报31.12元/股，成交7529.16万元，换手率3.46%，总市值33.70亿元。\n资金流向方面，主力资金净流出113.34万元，特大单买入136.74万元，占比1.82%，卖出359.16万元，占比4.77%；大单买入1764.47万元，占比23.44%，卖出1655.39万元，占比21.99%。\n科源制药今年以来股价涨6.21%，近5个交易日涨8.02%，近20日涨18.51%，近60日跌6.07%。\n资料显示，山东科源制药股份有限公司位于山东济南市山东商河经济开发区科源街，成立日期2004年12月27日，上市日期2023年4月4日，公司主营业务涉及化学原料药、成品药及医药化工中间体的研发、生产和销售。主营业务收入构成为：化学原料药44.77%，化学药品制剂41.41%，中间体12.47%，其他1.35%。\n科源制药所属申万行业为：医药生物-化学制药-原料药。所属概念板块包括：小盘、数字经济、并购重组、融资融券、维生素等。\n截至9月30日，科源制药股东户数1.11万，较上期减少11.26%；人均流通股6211股，较上期增加12.69%。2025年1月-9月，科源制药实现营业收入3.03亿元，同比减少8.52%；归母净利润3147.07万元，同比减少20.69%。\n分红方面，科源制药A股上市后累计派现8508.50万元。\n机构持仓方面，截止2025年9月30日，科源制药十大流通股东中，中信保诚多策略混合(LOF)A（165531）退出十大流通股东之列。",
  "highlightText": "",
  "highlightTitle": "",
  "highlightThreadTitle": "",
  "language": "chinese",
  "sentiment": "negative",
  "categories": [
    "Economy, Business and Finance"
  ],
  "topics": [
    "Economy, Business and Finance->market and exchange",
    "Economy, Business and Finance->financial and economic news"
  ],
  "ai_allow": true,
  "has_canonical": false,
  "breaking": true,
  "webz_reporter": false,
  "external_links": [],
  "external_images": [],
  "internal_images": [],
  "entities": {
    "persons": [],
    "locations": [],
    "organizations": []
  },
  "syndication": {
    "syndicated": null,
    "syndicate_id": null,
    "first_syndicated": false
  },
  "trust": {
    "categories": [],
    "top_news": [
      "top_news_hk",
      "top_news_sg",
      "top_news_tw",
      "top_news"
    ],
    "bias": null,
    "source": {
      "type": null,
      "city": null,
      "state": null,
      "country": null,
      "domain_type": null,
      "agency": null,
      "organization_name": null
    }
  },
  "rating": null,
  "crawled": "2026-01-15T08:13:37.289+02:00",
  "updated": "2026-01-15T08:17:48.000+02:00"
}